Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias

BACKGROUND: Adherence to long-term chelation therapy in transfusion-dependent patients is critical to prevent iron overload-related complications. Once-daily deferasirox dispersible tablets (DT) have proven long-term efficacy and safety in patients ≥2 years old with chronic transfusional iron overlo...

Full description

Saved in:
Bibliographic Details
Published in:Health Qual Life Outcomes
Main Authors: Taher, Ali T., Origa, Raffaella, Perrotta, Silverio, Kouraklis, Alexandra, Ruffo, Giovan Battista, Kattamis, Antonis, Goh, Ai-Sim, Huang, Vicky, Zia, Aiesha, Herranz, Raquel Merino, Porter, John B.
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245526/
https://ncbi.nlm.nih.gov/pubmed/30453981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-018-1041-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items